⌕
Insmed · INSM · Nasdaq
Tenet 33 · Weak
Compare
$121.86−0.83%At closeTenet 33 · Weak
$121.86−1.02 (−0.83%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
$119.48−2.38 (−1.95%)
After hours: Nov 17, 2026, 5:11 PM ET

Insmed (INSM) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (72 new · 119 increased · 72 reduced · 23 closed · 18 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 304 filers, Sep 30, 2026
# 13F FUNDS
304
13F VALUE
$2.4B
20.7M shares
Not reported in the company's filings for this period.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 19, 2026Hudson PauldirectorAcquired · Grant / award6,139—↗
Oct 19, 2026Koppikar UtpaldirectorAcquired · Grant / award6,139—↗
Sep 9, 2026Brennan David RdirectorDisposed · Open-market sale25,000$124.00↗
Aug 17, 2026SHAROKY MELVIN MDdirectorDisposed · Open-market sale5,000$127.53↗
Aug 10, 2026Adsett RogerChief Operating OfficerAcquired · Option exercise82,280$13.67↗
Aug 10, 2026Adsett RogerChief Operating OfficerAcquired · Option exercise76,600$17.16↗
Aug 10, 2026Adsett RogerChief Operating OfficerAcquired · Option exercise80,970$30.46↗
Aug 10, 2026Adsett RogerChief Operating OfficerDisposed · Open-market sale239,850$133.27↗
Aug 10, 2026Adsett RogerChief Operating OfficerDisposed · Option exercise82,280Stock Option (right to buy)—↗
Aug 10, 2026Adsett RogerChief Operating OfficerDisposed · Option exercise76,600Stock Option (right to buy)—↗
Aug 10, 2026Adsett RogerChief Operating OfficerDisposed · Option exercise80,970Stock Option (right to buy)—↗
Aug 6, 2026Flammer Martina M.D.Chief Medical OfficerAcquired · Option exercise18,278$18.95↗
Aug 6, 2026Flammer Martina M.D.Chief Medical OfficerAcquired · Option exercise8,895$25.83↗
Aug 6, 2026Flammer Martina M.D.Chief Medical OfficerDisposed · Open-market sale8,895$127.00↗
Aug 6, 2026Flammer Martina M.D.Chief Medical OfficerDisposed · Open-market sale18,278$129.40↗
Aug 6, 2026Flammer Martina M.D.Chief Medical OfficerDisposed · Option exercise18,278Stock Option (right to buy)—↗
Aug 6, 2026Flammer Martina M.D.Chief Medical OfficerDisposed · Option exercise8,895Stock Option (right to buy)—↗
Jul 23, 2026Lewis WilliamChair and CEOAcquired · Option exercise6,260$30.46↗
Jul 23, 2026Lewis WilliamChair and CEOAcquired · Option exercise4,440$17.16↗
Jul 23, 2026Lewis WilliamChair and CEODisposed · Open-market sale4,828$105.62↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold Insmed?

Insmed was held by 304 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.